Cancer Research The Future of Cancer Research: Science and Patient Impact  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 32, 889-892, May 1, 1972]
© 1972 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fisher, J. C.
Right arrow Articles by Mannick, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fisher, J. C.
Right arrow Articles by Mannick, J. A.

The Effect of Polyinosinic-Polycytidylic Acid on the Immune Response of Mice to Antigenically Distinct Tumors1

Jack C. Fisher2, Sidney R. Cooperband and John A. Mannick

Departments of Medicine [S. R. C.] and Surgery [J. C. F., J. A. M.], Boston University School of Medicine, Boston, Massachusetts 02118

Polyinosinic-polycytidylic acid temporarily inhibits the growth rate of visible, transplanted tumors of both chemical (methylcholanthrene-induced fibrosarcomas) and viral (murine polyoma) origin with nearly equal facility. This effect is dose related and is associated with lymphopenia and death at high doses or following prolonged administration. Polyinosinic-polycytidylic acid produces a variable effect on humoral antibody production in normal mice and can suppress cellular immunity in normal hosts, as evidenced by prolongation of skin allograft survivals in pretreated recipients. Prior host immunosuppression with either sublethal X-irradiation or antilymphocyte serum does not eliminate the inhibition of tumors provoked by polyinosinic-polycytidylic acid administration, thus suggesting that some mechanism other than stimulation of the immune response of the host is responsible for the effects of this drug on malignant cells.

1 Supported by USPHS Grants AM 10824 and RO1-A1-08579.

2 Present address: Department of Plastic Surgery, University of Virginia Medical Center, Charlottesville, Va. 22901.

Received 3/22/71. Accepted 1/24/72.




This article has been cited by other articles:


Home page
Journal of Bioactive and Compatible PolymersHome page
L. Seymour
Review : Synthetic Polymers with Intrinsic Anticancer Activity
Journal of Bioactive and Compatible Polymers, January 1, 1991; 6(2): 178 - 216.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1972 by the American Association for Cancer Research.